The ALL Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What are the recent advances in immunotherapy for adult patients with ALL?

During the Acute Leukemia Forum (ALF) 2021, the ALL Hub spoke to Ibrahim T. Aldoss, City of Hope Comprehensive Cancer Center, Duarte, US. We asked, What are the recent advances in immunotherapy for adult patients with ALL?

What are the recent advances in immunotherapy for adult patients with ALL?

The introduction of immunotherapy has contributed towards significant progress in the treatment of adult patients with relapsed/refractory ALL. In this video, Aldoss discusses recent data on blinatumomab, CAR T-cell therapy, and other novel agents showing promising results in clinical trials and in the frontline setting.

 

Share: